Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EBIT (2020 - 2025)

Core Scientific's EBIT history spans 6 years, with the latest figure at -$119.3 million for Q4 2025.

  • For Q4 2025, EBIT rose 26.66% year-over-year to -$119.3 million; the TTM value through Dec 2025 reached -$243.0 million, down 1.52%, while the annual FY2025 figure was -$245.6 million, 72.87% down from the prior year.
  • EBIT for Q4 2025 was -$119.3 million at Core Scientific, down from -$54.8 million in the prior quarter.
  • Across five years, EBIT topped out at $102.2 million in Q4 2021 and bottomed at -$1.0 billion in Q2 2022.
  • The 5-year median for EBIT is -$26.5 million (2022), against an average of -$123.8 million.
  • The largest annual shift saw EBIT skyrocketed 982388.46% in 2021 before it crashed 71613.96% in 2022.
  • A 5-year view of EBIT shows it stood at $102.2 million in 2021, then tumbled by 722.64% to -$636.1 million in 2022, then surged by 100.63% to $4.0 million in 2023, then tumbled by 4147.08% to -$162.7 million in 2024, then grew by 26.66% to -$119.3 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's EBIT are -$119.3 million (Q4 2025), -$54.8 million (Q3 2025), and -$26.3 million (Q2 2025).